PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Aldeyra Therapeutics Reports the US FDA Acceptance of NDA for Priority Review of ADX-2191 for the Treatment of Primary Vitreoretinal Lymphoma

Aldeyra Therapeutics Reports the US FDA Acceptance of NDA for Priority Review of ADX-2191 for the Treatment of Primary Vitreoretin...

March 3, 2023

PharmaShots Weekly Snapshots (February 27 – March 03, 2023)

PharmaShots Weekly Snapshots (February 27 – March 03, 2023)

March 3, 2023

Flamingo Therapeutics Signed a Definitive Merger Agreement with Dynacure to Advance RNA-Targeted Oncology Therapies

Flamingo Therapeutics Signed a Definitive Merger Agreement with Dynacure to Advance RNA-Targeted Oncology Therapies

March 3, 2023

Neuro20 Technologies Receives the US FDA Clearance of Neuro20 PRO System for Treatment of Neuromuscular Injury and Disease

Neuro20 Technologies Receives the US FDA Clearance of Neuro20 PRO System for Treatment of Neuromuscular Injury and Disease

March 3, 2023

Santhera Reports the MAA Submission to the MHRA for Vamorolone to Treat Duchenne Muscular Dystrophy

Santhera Reports the MAA Submission to the MHRA for Vamorolone to Treat Duchenne Muscular Dystrophy

March 3, 2023

Avenue Therapeutics Entered into an Exclusive License Agreement with AnnJi to Develop and Commercialize AJ201 for Spinal and Bulbar Muscular Atrophy

Avenue Therapeutics Entered into an Exclusive License Agreement with AnnJi to Develop and Commercialize AJ201 for Spinal and Bulba...

March 3, 2023

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us